(33) investigated cystic fibrosis in vitro using air-liquid interface cultures and organoid models made from patient-derived nasal epithelial stem cells, and demonstrated that these models are appropriate for pharmacological testing of cystic fibrosis transmembrane conductance regulator (CFTR). This evidence concerns the gene CFTR and cystic fibrosis.